| Prev Close: | 104.24 |
|---|---|
| Open: | 104.32 |
| Bid: | 106.83 x 600 |
| Ask: | 106.87 x 200 |
| 1y Target Est: | 112.73 |
| Beta: | 0.54 |
| Next Earnings Date: | 22-Jul-13 |
| Day's Range: | 104.26 - 107.40 |
|---|---|
| 52wk Range: | 67.61 - 114.95 |
| Volume: | 1,382,584 |
| Avg Vol (3m): | 4,271,950 |
| Market Cap: | 79.89B |
| P/E (ttm): | 18.08 |
| EPS (ttm): | 5.91 |
| Div & Yield: | 1.88 (1.80%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Featured on Yahoo! Finance
Headlines
- Early Glance: Biotechnology companiesAP(Wed 10:51AM EDT)
- 1 Biotech, 1 Financial And 1 Consumer Goods Company With Recent Intensive Insider Sellingat Seeking Alpha(Wed 10:46AM EDT)
- AbbVie Reaches New Highs Thanks To Humiraat Seeking Alpha(Wed 7:48AM EDT)
- Stock Market News for May 22, 2013Zacks(Wed 6:40AM EDT)
- Immune system cancer drugs tipped to be a $35 bln marketat Reuters(Wed 5:33AM EDT)
- Final Glance: Biotechnology companiesAP(Tue, May 21)
- Amgen Inc (AMGN): Today's Featured Health Care Winnerat TheStreet(Tue, May 21)
- Opportunities in Hepatitis C and Genomic Technologies: a Wall Street Transcript Interview with David Ferreiro, Executive Director and Senior Analyst at Oppenheimer & Co. Inc.Wall Street Transcript(Tue, May 21)
- Midday Glance: Biotechnology companiesAP(Tue, May 21)
- Extra Space Storage Executive Chairman Sells More Than 79K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Tue, May 21)
- Is There a Pill For That? Forest Labs’ Iffy PipelineYCharts(Tue, May 21)
- New Asthma Drug Generates Excitement For Patients -- And Its Makerat Forbes(Tue, May 21)
- Today’s 3 Worst Stocksat Motley Fool(Mon, May 20)
- Lightning Round: CarMax, Asbury Automotive & Moreat CNBC(Mon, May 20)
- Sector Rotation? Amgen vs. Appleat Barrons.com(Mon, May 20)
Press Releases
- Amgen To Present At The UBS Global Life Sciences ConferencePR Newswire(Thu, May 16)
- New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal CancerPR Newswire(Wed, May 15)
- Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual MeetingPR Newswire(Wed, May 15)
Reports
- AMGN: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 22)
- ValuEngine Industry Report for Medical-biomed/geneticsValuEngine, Inc.(May 22)
- Trading Report for (AMGN). A detailed report, including free correlated market...Stock Traders Daily(May 22)